Bodin Stéphane, Elhabashy Hadeer, Macdonald Ewan, Winter Dominic, Gauthier-Rouvière Cécile
CRBM (Centre de Recherche en Biologie cellulaire de Montpellier), BIOLuM, University of Montpellier, CNRS UMR 5237, Montpellier, France.
Department of Protein Evolution, Max Planck Institute for Biology, Tübingen, Germany.
Biol Cell. 2025 Jan;117(1):e2400134. doi: 10.1111/boc.202400134.
Flotillin 1 and 2 are highly conserved and homologous members of the stomatin, prohibitin, flotillin, HflK/C (SPFH) family. These ubiquitous proteins assemble into hetero-oligomers at the cytoplasmic membrane in sphingolipid-enriched domains. Flotillins play crucial roles in various cellular processes, likely by concentrating sphingosine. They primarily act as scaffolding protein complexes within membrane microdomains (also called lipid rafts) and induce endocytosis and trafficking. Their diverse cargos in the upregulated flotillin-induced trafficking (UFIT) pathway, including tyrosine kinase receptors, adhesion molecules, and neurotransmitter receptors, link them to a wide range of cellular processes and diseases. Consequently, flotillin upregulation has been associated with various pathological conditions such as cancer, metabolic disorders, and neurodegenerative diseases. Flotillins may also be co-opted by pathogens to facilitate their entry and growth within host cells. In this review, we examined recent advancements in elucidating the structure and functions of the flotillin protein complex, including its implications in favoring the generation of sphingosine 1-phosphate, an essential bioactive lipid. We emphasized how the recent cryo-electron microscopy (cryo-EM) structure of a truncated cone-shaped cage composed of 22 copies of flotillin 1 and 2 subunits has enhanced our understanding of the flotillin complex organization within membrane microdomains and its role in membrane remodeling. We also explored how flotillin upregulation can perturb endosomal trafficking and contribute to various pathologies. A comprehensive understanding of flotillin oligomer organization and function is crucial to developing targeted therapies for diseases associated with flotillin overexpression.
Flotillin 1和Flotillin 2是stomatin、prohibitin、flotillin、HflK/C(SPFH)家族中高度保守且同源的成员。这些普遍存在的蛋白质在富含鞘脂的细胞质膜结构域中组装成异源寡聚体。Flotillin在各种细胞过程中发挥关键作用,可能是通过富集鞘氨醇来实现的。它们主要作为膜微结构域(也称为脂筏)内的支架蛋白复合物,诱导内吞作用和运输。在Flotillin上调诱导的运输(UFIT)途径中,它们的多种货物,包括酪氨酸激酶受体、黏附分子和神经递质受体,将它们与广泛的细胞过程和疾病联系起来。因此,Flotillin上调与各种病理状况相关,如癌症、代谢紊乱和神经退行性疾病。病原体也可能利用Flotillin来促进其在宿主细胞内的进入和生长。在这篇综述中,我们研究了在阐明Flotillin蛋白复合物的结构和功能方面的最新进展,包括其在促进鞘氨醇-1-磷酸生成方面的意义,鞘氨醇-1-磷酸是一种重要的生物活性脂质。我们强调了由22个Flotillin 1和2亚基拷贝组成的截短锥形笼状结构的低温电子显微镜(cryo-EM)结构如何增强了我们对膜微结构域内Flotillin复合物组织及其在膜重塑中的作用的理解。我们还探讨了Flotillin上调如何扰乱内体运输并导致各种病理状况。全面了解Flotillin寡聚体的组织和功能对于开发针对与Flotillin过表达相关疾病的靶向治疗至关重要。